SY
Putnam BioRevolution ETF
SYNB · AMEX
$31.61 -0.37% (-$0.12)
Market Cap ¥37.4M
P/E Ratio -159.26x
Div. Yield 0.68%
ROE -
Valuation
65 /100
Fair P/S 0.02x
P/B 0.01x
P/E -159.26x
Growth
55 /100
Stable Rev. growth 17.83%
Book val. growth 4.57%
EPS growth 9.23%
Profitability
0 /100
Weak Op. margin 119.05%
Net margin 90.07%
FCF margin N/A
Quality
30 /100
Poor Asset turnover 0.17x
ROA 15.38%
ROE N/A
Debt
100 /100
Low Current ratio 1.23x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
70 /100
Stable Rev. volatility 69.90%
EPS volatility 11.76%
Profitable years 6
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre SYNB
Online
Sector
Financial Services
Industry
Asset Management
CEO
-
Employees
-
Headquarters
San Mateo